PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.10%
Negative revenue growth while INTC stands at 3.78%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.45%
Negative gross profit growth while INTC is at 1.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
8.36%
EBIT growth above 1.5x INTC's 1.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
-5.45%
Negative operating income growth while INTC is at 1.43%. Joel Greenblatt would press for urgent turnaround measures.
8.16%
Net income growth 1.25-1.5x INTC's 5.45%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
4.00%
EPS growth at 50-75% of INTC's 5.63%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
4.08%
Diluted EPS growth at 50-75% of INTC's 5.80%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.51%
Share reduction while INTC is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share count expanding well above INTC's 0.08%. Michael Burry would fear significant dilution to existing owners' stakes.
31.30%
Dividend growth above 1.5x INTC's 0.14%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-1.84%
Negative OCF growth while INTC is at 41.54%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.24%
FCF growth under 50% of INTC's 40.21%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
45.31%
10Y revenue/share CAGR under 50% of INTC's 105.62%. Michael Burry would suspect a lasting competitive disadvantage.
13.86%
5Y revenue/share CAGR at 50-75% of INTC's 26.33%. Martin Whitman would worry about a lagging mid-term growth trajectory.
22.94%
3Y revenue/share CAGR similar to INTC's 24.26%. Walter Schloss would assume both companies experience comparable short-term cycles.
141.93%
10Y OCF/share CAGR in line with INTC's 136.11%. Walter Schloss would see both as similarly efficient over the decade.
62.92%
5Y OCF/share CAGR above 1.5x INTC's 31.70%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
26.13%
3Y OCF/share CAGR at 50-75% of INTC's 41.71%. Martin Whitman would suspect weaker recent execution or product competitiveness.
131.02%
Net income/share CAGR at 50-75% of INTC's 188.88%. Martin Whitman might question if the firm’s product or cost base lags behind.
300.73%
5Y net income/share CAGR above 1.5x INTC's 13.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
123.41%
3Y net income/share CAGR above 1.5x INTC's 42.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
35.88%
Below 50% of INTC's 119.36%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
9.07%
Below 50% of INTC's 54.55%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.67%
Below 50% of INTC's 19.35%. Michael Burry suspects a serious short-term disadvantage in building book value.
1168.08%
10Y dividend/share CAGR above 1.5x INTC's 160.58%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
194.90%
5Y dividend/share CAGR above 1.5x INTC's 23.46%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.90%
3Y dividend/share CAGR above 1.5x INTC's 15.47%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-12.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.33%
Asset growth 1.25-1.5x INTC's 0.99%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
2.34%
Under 50% of INTC's 4.91%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.83%
Our R&D shrinks while INTC invests at 6.88%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.01%
We cut SG&A while INTC invests at 7.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.